Bavachin from psoralea corylifolia improves insulin-dependent glucose uptake through insulin signaling and AMPK activation in 3T3-L1 adipocytes

International Journal of Molecular Sciences

Volumn 17, Issue 4, 2016, Pages

  Lee, Hyejin ^a   Li, Hua ^a   Noh, Minsoo ^b   Ryu, Jae Ha ^a  

^a Sookmyung Women's University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

3T3 L1; Adipogenesis; Diabetes mellitus; Glucose uptake; Psoralea corylifolia

Indexed keywords

BAKUCHIOL; BAVACHIN; BAVACHININ; CCAAT ENHANCER BINDING PROTEIN ALPHA; CORYLIN; FLAVONOID; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; KANZONOL B; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; PSORALEA CORYLIFOLIA EXTRACT; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; GLUCOSE; INSULIN;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CULLEN CORYLIFOLIUM; GENE EXPRESSION; GLUCOSE TRANSPORT; IMMUNOFLUORESCENCE; INFRARED SPECTROSCOPY; LIPID STORAGE; MTT ASSAY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLANT SEED; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; WESTERN BLOTTING; 3T3-L1 CELL LINE; ANIMAL; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; ENZYME ACTIVATION; METABOLISM; MOUSE; PSORALEA; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

3T3-L1 CELLS; ADIPOCYTES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BIOLOGICAL TRANSPORT; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; FLAVONOIDS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; INSULIN; MICE; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; PSORALEA; SIGNAL TRANSDUCTION;

EID: 84962891460     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17040527     Document Type: Article

References (35)

1. Kwon, D.Y.; Kim da, S.; Yang, H.J.; Park, S. The lignan-rich fractions of Fructus Schisandrae improve insulin sensitivity via the PPAR-pathways in in vitro and in vivo studies. J. Ethnopharmacol. 2011, 135, 455–462.
2. Joo, J.I.; Kim, D.H.; Yun, J.W. Extract of Chaga mushroom (Inonotus obliquus) stimulates 3T3-L1 adipocyte differentiation. Phytother. Res. 2010, 24, 1592–1599.
3. Khushboo, P.S.; Jadhav, V.M.; Kadam, V.J.; Sathe, N.S. Psoralea corylifolia Linn.—“Kushtanashini”. Pharmacogn. Rev. 2010, 4, 69–76.
4. Kamboj, J.; Sharma, S.; Kumar, S. In vivo Anti-diabetic and anti-oxidant potential of Psoralea corylifolia seeds in Streptozotocin induced type-2 diabetic rats. J. Health Sci. 2011, 57, 225–235.
5. Seo, E.; Lee, E.K.; Lee, C.S.; Chun, K.H.; Lee, M.Y.; Jun, H.S. Psoralea corylifolia L. seed extract ameliorates streptozotocin-induced diabetes in mice by inhibition of oxidative stress. Oxid. Med. Cell. Longev. 2014, 2014, 897296.
6. Bera, T.K.; Ali, K.M.; Jana, K.; Ghosh, A.; Ghosh, D. Protective effect of aqueous extract of seed of Psoralea corylifolia (Somraji) and seed of Trigonella foenum-graecum L. (Methi) in streptozotocin-induced diabetic rat: A comparative evaluation. Pharmacogn. Res. 2013, 5, 277–285.
7. Suhashini, R.; Sindhu, S.; Sagadevan, E. In vitro evaluation of anti diabetic potential and phytochemical profile of Psoralea corylifolia seeds. Int. J. Pharmacogn. Phytochem. Res. 2014, 6, 414–419.
8. Krenisky, J.M.; Luo, J.; Reed, M.J.; Carney, J.R. Isolation and antihyperglycemic activity of bakuchiol from Otholobium pubescens (Fabaceae), a Peruvian medicinal plant used for the treatment of diabetes. Biol. Pharm. Bull. 1999, 22, 1137–1140.
9. Cecilia, L.; Faini, F.; Joseph, C.; Hoshph, D.C. Bakuchiol derivatives from the leaves of Psoalea grandulosa. Phytochemistry 1996, 42, 1299–1303.
10. Wang, D.; Li, F.; Jiang, Z. Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. Planta Med. 2001, 67, 748–749.
11. Vaidya, H.; Goyal, R.K.; Cheema, S.K. Anti-diabetic activity of swertiamarin is due to an active metabolite, gentianine, that upregulates PPAR-gene expression in 3T3-L1 cells. Phytother. Res. 2013, 27, 624–627.
12. Yamauchi, T.; Kamon, J.; Waki, H.; Murakami, K.; Motojima, K.; Komeda, K.; Ide, T.; Kubota, N.; Terauchi, Y.; Tobe, K.; et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor (PPAR) deficiency and PPAR agonist improve insulin resistance. J. Biol. Chem. 2001, 276, 41245–41254.
13. Chopra, B.; Dhingra, A.K.; Dhar, K.L. Psoralea corylifolia L. (Buguchi)—Folklore to modern evidence: Review. Fitoterapia 2013, 90, 44–56.
14. Du, G.; Feng, L.; Yang, Z.; Shi, J.; Huang, C.; Guo, F.; Li, B.; Zhu, W.; Li, Y. Separation and peroxisome proliferator-activated receptor-agonist activity evaluation of synthetic racemic bavachinin enantiomers. Bioorg. Med. Chem. Lett. 2015, 25, 2579–2583.
15. Cho, K.W.; Lee, O.H.; Banz, W.J.; Moustaid-Moussa, N.; Shay, N.F.; Kim, Y.C. Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPAR transcriptional activity. J. Nutr. Biochem. 2010, 21, 841–847.
16. Tang, Q.Q.; Otto, T.C.; Lane, M.D. CCAAT/enhancer-binding protein _ is required for mitotic clonal expansion during adipogenesis. Proc. Natl. Acad. Sci. USA 2003, 100, 850–855.
17. Leonardini, A.; Laviola, L.; Perrini, S.; Natalicchio, A.; Giorgino, F. Cross-talk between PPAR and insulin signaling and modulation of insulin sensitivity. PPAR Res. 2009, 2009, 818945.
18. De Souza, C.J.; Eckhardt, M.; Gagen, K.; Dong, M.; Chen, W.; Laurent, D.; Burkey, B.F. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 2001, 50, 1863–1871.
19. Takamura, T.; Nohara, E.; Nagai, Y.; Kobayashi, K. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPAR mRNA expression in 3T3-L1 adipocytes. Eur. J. Pharmacol. 2001, 422, 23–29.
20. Skrzypski, M.; Kaczmarek, P.; Le, T.T.; Wojciechowicz, T.; Pruszynska-Oszmalek, E.; Szczepankiewicz, D.; Sassek, M.; Arafat, A.; Wiedenmann, B.; Nowak, K.W.; et al. Effects of orexin A on proliferation, survival, apoptosis and differentiation of 3T3-L1 preadipocytes into mature adipocytes. FEBS Lett. 2012, 586, 4157–4164.
21. Skrzypski, M.; Le, T.T.; Kaczmarek, P.; Pruszynska-Oszmalek, E.; Pietrzak, P.; Szczepankiewicz, D.; Kolodziejski, P.A.; Sassek, M.; Arafat, A.; Wiedenmann, B.; et al. Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes. Diabetologia 2011, 54, 1841–1852.
22. Kopp, C.; Hosseini, A.; Singh, S.P.; Regenhard, P.; Khalilvandi-Behroozyar, H.; Sauerwein, H.; Mielenz, M. Nicotinic acid increases adiponectin secretion from differentiated bovine preadipocytes through G-protein coupled receptor signaling. Int. J. Mol. Sci. 2014, 15, 21401–21418.
23. Whitehead, J.P.; Richards, A.A.; Hickman, I.J.; Macdonald, G.A.; Prins, J.B. Adiponectin—A key adipokine in the metabolic syndrome. Diabetes Obes. Metab. 2006, 8, 264–280.
24. Litherland, G.J.; Hajduch, E.; Hundal, H.S. Intracellular signalling mechanisms regulating glucose transport in insulin-sensitive tissues (review). Mol. Membr. Biol. 2001, 18, 195–204.
25. Sano, H.; Eguez, L.; Teruel, M.N.; Fukuda, M.; Chuang, T.D.; Chavez, J.A.; Lienhard, G.E.; McGraw, T.E. Rab10, a target of the AS160 Rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane. Cell Metab. 2007, 5, 293–303.
26. Fu, Y.; Luo, N.; Klein, R.L.; Garvey, W.T. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J. Lipid Res. 2005, 46, 1369–1379.
27. Eguez, L.; Lee, A.; Chavez, J.A.; Miinea, C.P.; Kane, S.; Lienhard, G.E.; McGraw, T.E. Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab. 2005, 2, 263–272.
28. Ha do, T.; Trung, T.N.; Hien, T.T.; Dao, T.T.; Yim, N.; Ngoc, T.M.; Oh, W.K.; Bae, K. Selected compounds derived from Moutan Cortex stimulated glucose uptake and glycogen synthesis via AMPK activation in human HepG2 cells. J. Ethnopharmacol. 2010, 131, 417–424.
29. Lee, M.S.; Hwang, J.T.; Kim, S.H.; Yoon, S.; Kim, M.S.; Yang, H.J.; Kwon, D.Y. Ginsenoside Rc, an active component of Panax ginseng, stimulates glucose uptake in C2C12 myotubes through an AMPK-dependent mechanism. J. Ethnopharmacol. 2010, 127, 771–776.
30. Russo, G.L.; Russo, M.; Ungaro, P. AMP-activated protein kinase: A target for old drugs against diabetes and cancer. Biochem. Pharmacol. 2013, 86, 339–350.
31. Gasparrini, M.; Giampieri, F.; Alvarez Suarez, J.M.; Mazzoni, L.; Forbes Hernandez, T.Y.; Quiles, J.L.; Bullon, P.; Battino, M. AMPK as a new attractive therapeutic target for disease prevention: The role of dietary compounds. Curr. Drug Targets 2015, 16.
32. Lee, M.H.; Kim, J.Y.; Ryu, J.H. Prenylflavones from Psoralea corylifolia inhibit nitric oxide synthase expression through the inhibition of I-κB-κ degradation in activated microglial cells. Biol. Pharm. Bull. 2005, 28, 2253–2257.
33. Lee, S.W.; Yun, B.R.; Kim, M.H.; Park, C.S.; Lee, W.S.; Oh, H.M.; Rho, M.C. Phenolic compounds isolated from Psoralea corylifolia inhibit IL-6-induced STAT3 activation. Planta Med. 2012, 78, 903–906.
34. Ngadjui, B.T.; Watchueng, J.; Keumedjio, F.; Ngameni, B.; Simo, I.K.; Abegaz, B.M. Prenylated chalcones, flavone and other constituents of the twigs of Dorstenia angusticornis and Dorstenia barteri var. subtriangularis. Phytochemistry 2005, 66, 687–692.
35. Hwang, J.; Lee, S.J.; Yoo, M.; Go, G.Y.; Lee da, Y.; Kim, Y.K.; Seo, D.W.; Kang, J.S.; Ryu, J.H.; Bae, G.U. Kazinol-P from Broussonetia kazinoki enhances skeletal muscle differentiation via p38MAPK and MyoD. Biochem. Biophys. Res. Commun. 2015, 456, 471–475.